Antimicrobial prophylaxis of experimental endocarditis caused by Staphylococcus epidermidis

Area of Science:

• Microbiology
• Pharmacology
• Infectious Diseases

Background:

• Staphylococcus epidermidis is a common cause of healthcare-associated infections, including endocarditis.
• Methicillin resistance in S. epidermidis poses a therapeutic challenge.
• Experimental models are crucial for evaluating antibiotic efficacy.

Purpose of the Study:

• To evaluate the prophylactic efficacy of cefamandole, cefazolin, nafcillin, and vancomycin against Staphylococcus epidermidis endocarditis in rats.
• To compare the effectiveness of these antibiotics against methicillin-resistant and susceptible strains.

Main Methods:

• A rat model of experimental endocarditis was established using two strains of S. epidermidis.
• Antibiotic susceptibility testing was performed in vitro.
• Animals received prophylactic antibiotic treatment prior to bacterial challenge.
• Efficacy was assessed by infection rates and bacterial load.

Main Results:

• Both S. epidermidis strains were resistant to methicillin and cefazolin, but susceptible to cefamandole and vancomycin.
• Cefamandole (84.0%) and cefazolin (70.8%) showed similar prophylactic efficacy.
• Vancomycin demonstrated high efficacy (94.4% and 86.7%).
• Nafcillin's efficacy varied significantly between the two strains (62.5% vs. 38.5%).

Conclusions:

• Cefamandole and cefazolin may offer prophylactic benefits against certain methicillin-resistant S. epidermidis strains.
• High-dose cephalosporin administration showed promise in this animal model.
• Further research is warranted to optimize treatment strategies for S. epidermidis endocarditis.